Amin Rostami-Hodjegan
Chief Tech/Sci/R&D Officer bei CERTARA, INC.
Profil
Amin Rostami-Hodjegan was the founder of Certara UK Ltd.
(founded in 2001) and held the title of Director-Scientific Research & Development in 2012.
Dr. Rostami-Hodjegan's current job(s) include being the Director at the Centre For Applied Pharmacokinetic Research, Professor-Systems Pharmacology at The University of Manchester (since 2015), Chief Scientific Officer at Certara USA, Inc., and Chief Scientific Officer at Certara, Inc. Dr. Rostami-Hodjegan's former job(s) include being the Director-Research & Development at The University of Sheffield and a Non-Executive Director at Zilico Ltd.
Dr. Rostami-Hodjegan obtained a doctorate degree from The University of Sheffield in 1996 and an undergraduate degree from the University of Tabriz in 1987.
Aktive Positionen von Amin Rostami-Hodjegan
| Unternehmen | Position | Beginn |
|---|---|---|
| CERTARA, INC. | Chief Tech/Sci/R&D Officer | - |
Certara USA, Inc.
 Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | - |
| The University of Manchester | Corporate Officer/Principal | 01.01.2001 |
| Centre For Applied Pharmacokinetic Research | Director/Board Member | - |
Ehemalige bekannte Positionen von Amin Rostami-Hodjegan
| Unternehmen | Position | Ende |
|---|---|---|
| The University of Sheffield | Chief Tech/Sci/R&D Officer | 08.12.2010 |
Zilico Ltd.
 Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | - |
Certara UK Ltd.
 Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Founder | - |
Ausbildung von Amin Rostami-Hodjegan
| The University of Sheffield | Doctorate Degree |
| University of Tabriz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Private Unternehmen | 4 |
|---|---|
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Health Technology |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
| Centre For Applied Pharmacokinetic Research |
